Verastem Oncology
VSTM
$11.42
Share price
-3.55%
Change (1 day)
2,619.05%
Change (1 year)
Categories
Verastem Oncology (VSTM) - Total debt
Total debt on the balance sheet as of December 2023 : $41.55 M
According to Verastem Oncology 's latest financial reports the company's total debt is $41.55 M. A company’s total debt is the sum of all current and non-current debts.
Verastem Oncology - Total debt on balance sheet (from 2017 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $27.06 M | 751.1% |
| 2021-12-31 | $3.18 M | -85.89% |
| 2020-12-31 | $22.54 M | -79.04% |
| 2019-12-31 | $0.10 B | -10.73% |
| 2018-12-31 | $0.12 B | 712.33% |
| 2017-12-31 | $14.82 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $70.84 B | 170,376.69% | 🇺🇸 USA |
 LabCorp LH | $5.96 B | 14,262.20% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.45 B | 53,943.84% | 🇬🇧 UK |
 Curis CRIS | $2.79 M | -93.28% | 🇺🇸 USA |